FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002252641> ?p ?o ?g. }

• W2002252641 abstract "The converting enzyme inhibitor enalapril, in single daily doses of 10 to 40 mg, was given to 20 hypertensive patients with renal artery stenosis. The decrease in blood pressure six hours after the first dose of enalapril was significantly related to the pretreatment plasma concentrations of active renin and angiotensin II, and to the concurrent decrease in angiotensin II. Blood pressure decreased further with continued treatment; the long-term decrease was not significantly related to pretreatment plasma renin or angiotensin II levels. At three months, 24 hours after the last dose of enalapril, blood pressure, plasma angiotensin II, and converting enzyme activity remained low, and active renin and angiotensin I high; six hours after dosing, angiotensin II had, however, decreased further. The increase in active renin during long-term treatment was proportionately greater than the increase in angiotensin I; this probably reflects the diminution in renin substrate that occurs with converting enzyme inhibition. Long-term enalapril treatment increased renin secretion by more than 10-fold, and renal venous and peripheral plasma renin concentration by more than 20-fold; however, the mean renal venous renin ratio was not changed. Enalapril caused a reduction in effective renal plasma flow via the affected kidney but a marked and consistent increase on the contralateral side, where renal vascular resistance decreased. The overall increase in effective renal plasma flow was significantly related to the decrease in angiotensin II. Overall glomerular filtration rate was lowered, and serum creatinine and urea increased. Enalapril alone caused a long-term reduction in exchangeable sodium, with slight but distinct increases in serum potassium. In five patients with bilateral renal artery lesions, enalapril given alone for three months did not cause renal function to deteriorate. Enalapril was well tolerated and provided effective long-term control of hypertension; only two of the 20 patients studied required concomitant diuretic treatment." @default.
• W2002252641 created "2016-06-24" @default.
• W2002252641 creator A5007401350 @default.
• W2002252641 creator A5009671476 @default.
• W2002252641 creator A5012174041 @default.
• W2002252641 creator A5039557075 @default.
• W2002252641 creator A5042148457 @default.
• W2002252641 creator A5043601653 @default.
• W2002252641 creator A5045982685 @default.
• W2002252641 creator A5064571435 @default.
• W2002252641 creator A5079327811 @default.
• W2002252641 date "1984-08-01" @default.
• W2002252641 modified "2023-09-26" @default.
• W2002252641 title "Enalapril in Treatment of Hypertension with Renal Artery Stenosis" @default.
• W2002252641 cites W1526103115 @default.
• W2002252641 cites W176915205 @default.
• W2002252641 cites W1963716376 @default.
• W2002252641 cites W1966771512 @default.
• W2002252641 cites W1972442875 @default.
• W2002252641 cites W1974461027 @default.
• W2002252641 cites W1976346162 @default.
• W2002252641 cites W1985333011 @default.
• W2002252641 cites W1987000855 @default.
• W2002252641 cites W2000957626 @default.
• W2002252641 cites W2002005841 @default.
• W2002252641 cites W2005971005 @default.
• W2002252641 cites W2007277382 @default.
• W2002252641 cites W2009120749 @default.
• W2002252641 cites W2014019411 @default.
• W2002252641 cites W2017683502 @default.
• W2002252641 cites W2017902080 @default.
• W2002252641 cites W2031689625 @default.
• W2002252641 cites W2035909309 @default.
• W2002252641 cites W2055868493 @default.
• W2002252641 cites W2059996965 @default.
• W2002252641 cites W2062503679 @default.
• W2002252641 cites W2064692573 @default.
• W2002252641 cites W2079138620 @default.
• W2002252641 cites W2086524451 @default.
• W2002252641 cites W2087379291 @default.
• W2002252641 cites W2166168086 @default.
• W2002252641 cites W2168437815 @default.
• W2002252641 cites W2305919962 @default.
• W2002252641 cites W2306460108 @default.
• W2002252641 cites W2322461415 @default.
• W2002252641 cites W2409612016 @default.
• W2002252641 cites W2412909336 @default.
• W2002252641 cites W2474232380 @default.
• W2002252641 cites W2599195209 @default.
• W2002252641 cites W2184258485 @default.
• W2002252641 doi "https://doi.org/10.1016/s0002-9343(84)80058-3" @default.
• W2002252641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6089557" @default.
• W2002252641 hasPublicationYear "1984" @default.
• W2002252641 type Work @default.
• W2002252641 sameAs 2002252641 @default.
• W2002252641 citedByCount "36" @default.
• W2002252641 countsByYear W20022526412013 @default.
• W2002252641 countsByYear W20022526412018 @default.
• W2002252641 crossrefType "journal-article" @default.
• W2002252641 hasAuthorship W2002252641A5007401350 @default.
• W2002252641 hasAuthorship W2002252641A5009671476 @default.
• W2002252641 hasAuthorship W2002252641A5012174041 @default.
• W2002252641 hasAuthorship W2002252641A5039557075 @default.
• W2002252641 hasAuthorship W2002252641A5042148457 @default.
• W2002252641 hasAuthorship W2002252641A5043601653 @default.
• W2002252641 hasAuthorship W2002252641A5045982685 @default.
• W2002252641 hasAuthorship W2002252641A5064571435 @default.
• W2002252641 hasAuthorship W2002252641A5079327811 @default.
• W2002252641 hasConcept C119584498 @default.
• W2002252641 hasConcept C126322002 @default.
• W2002252641 hasConcept C134018914 @default.
• W2002252641 hasConcept C138976137 @default.
• W2002252641 hasConcept C142225936 @default.
• W2002252641 hasConcept C159641895 @default.
• W2002252641 hasConcept C198710026 @default.
• W2002252641 hasConcept C21652263 @default.
• W2002252641 hasConcept C27016395 @default.
• W2002252641 hasConcept C2775940317 @default.
• W2002252641 hasConcept C2908929049 @default.
• W2002252641 hasConcept C71924100 @default.
• W2002252641 hasConcept C84393581 @default.
• W2002252641 hasConceptScore W2002252641C119584498 @default.
• W2002252641 hasConceptScore W2002252641C126322002 @default.
• W2002252641 hasConceptScore W2002252641C134018914 @default.
• W2002252641 hasConceptScore W2002252641C138976137 @default.
• W2002252641 hasConceptScore W2002252641C142225936 @default.
• W2002252641 hasConceptScore W2002252641C159641895 @default.
• W2002252641 hasConceptScore W2002252641C198710026 @default.
• W2002252641 hasConceptScore W2002252641C21652263 @default.
• W2002252641 hasConceptScore W2002252641C27016395 @default.
• W2002252641 hasConceptScore W2002252641C2775940317 @default.
• W2002252641 hasConceptScore W2002252641C2908929049 @default.
• W2002252641 hasConceptScore W2002252641C71924100 @default.
• W2002252641 hasConceptScore W2002252641C84393581 @default.
• W2002252641 hasLocation W20022526411 @default.
• W2002252641 hasLocation W20022526412 @default.
• W2002252641 hasOpenAccess W2002252641 @default.
• W2002252641 hasPrimaryLocation W20022526411 @default.
• W2002252641 hasRelatedWork W1983486737 @default.
• W2002252641 hasRelatedWork W1987491491 @default.

• next